StockData
Trinity Biotech PLC logo

Trinity Biotech PLC (TRIB) stock

TRIBNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 1/30
$5.83−0.18 (-3.08%)

Close on Nov 18, 2026Market cap $108.99MP/E –Yield –

Trinity Biotech market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Trinity Biotech's market cap was $108.11M on Nov 11, 2026, against $563.09M a year earlier. Over the last 5 years it ranged from $108.11M to $786.71M, with a median of $350.25M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$108.11M-74.6%
2025Dec 31, 2025$426.23M+110.8%
2024Dec 31, 2024$202.16M-21.0%
2023Dec 29, 2023$255.96M-6.8%
2022Dec 30, 2022$274.69M-32.2%
2021Dec 31, 2021$404.90M-86.1%
2020Dec 31, 2020$2.91B+262.8%
2019Dec 31, 2019$802.33M-56.6%
2018Dec 31, 2018$1.85B-57.4%
2017Dec 29, 2017$4.33B-23.9%
2016Dec 30, 2016$5.69B–

More Trinity Biotech figures

See a number that looks wrong?